To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males
Status:
Recruiting
Trial end date:
2023-06-10
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, single-dose per period, two-period, crossover study to
evaluate the relative bioavailability of decitabine and tetrahydrouridine ingested as a
modified-release combination formulation compared to THU and decitabine ingested as
immediate-release capsules